SILENCE THERAP. SP.ADR/1 (XRP2) — Free Cash Flow Generation Index

Latest as of December 2021: 0.80x

SILENCE THERAP. SP.ADR/1 (XRP2) has a Free Cash Flow Generation Index of 0.80x as of December 2021. Free cash flow of €7.39 Million represents 1% of operating cash flow (€9.19 Million). See XRP2 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.80x
Free Cash Flow / Operating CF

Free Cash Flow

€7.39 Million
EUR

Operating Cash Flow

€9.19 Million
EUR

Capital Expenditures

€1.80 Million
EUR

SILENCE THERAP. SP.ADR/1 Free Cash Flow Generation Index (2021–2021)

Historical FCF Generation Index trend for SILENCE THERAP. SP.ADR/1 across 1 annual periods. Explore debt repayment capacity of SILENCE THERAP. SP.ADR/1 to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for SILENCE THERAP. SP.ADR/1 (2021–2021)

Year-by-year Free Cash Flow Generation Index for SILENCE THERAP. SP.ADR/1. For the full company profile including market capitalisation, see XRP2 company net worth.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2021 0.80x €7.39 Million €9.19 Million €1.80 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).